教育背景

2010/09-2015/06，四川大学，再生医学研究中心，硕博连读

2006/09-2010/06，曲阜师范大学，生命科学学院，本科

2015/07-至今，聊城大学，药学院，讲师

科研项目

1.国家自然科学基金面上项目，81273419，融合高亲和性肿瘤导向肽增强sTRAIL抗肿瘤作用及机制研究，参加

2.国家自然科学基金面上项目，81172868，T细胞活化和增殖共抑制双功能分子的构建及其在类风湿性关节炎实验治疗中的应用，参加

3.青年科学基金项目，81102366，CendR基序肿瘤导向肽iTNP的组织穿透性及其作为药物载体的研究，参加

研究方向

重组蛋白药物、肿瘤靶向药物

(1)DianlongJia#,HaoYang,ZeTao,LinWan,JingqiuCheng,XiaofengLu*,Preparationandcharacterizationofanovelvariantofhumantumornecrosisfactor-relatedapoptosis-inducingligandfromtherhesusmonkey,Macacamulatta,AppliedMicrobiologyandBiotechnology,2015,69(5):AB337.

(2)DianlongJia#,HaoYang,LinWan,JingqiuCheng,XiaofengLu*,Productionofbioactive,SUMO-modified,andnative-likeTNF-αoftherhesusmonkey,Macacamulatta,inEscherichiacoli,AppliedMicrobiologyandBiotechnology,2012,93(6):2345-2355.

(3)NieQ#,JiaD#,YangH,etal.Conjugationto10kDalinearPEGextendsserumhalf-lifeandpreservesthereceptor-bindingabilityofmmTRAILwithminimalstimulationofPEG-specificantibodies.MolPharm,2016.

(4)TaoSu#,HaoYang,QingFan,DianlongJia,LinWan,ZeTao,LinWan,XiaofengLu*,Enhancingthecirculatinghalf-lifeandtheantitumoreffectsofatumor-selectivecytotoxicpeptidebyexploitingendogenousserumalbuminasadrugcarrier,InternationalJournalofPharmaceutics,2016,499(1-2).

(5)ZeTao#,YangHao,DianlongJia,LinWan,JingqiuCheng,XiaofengLu*,Molecularcloning,recombinantexpressionandcharacterizationofGMCSFfromtherhesusmonkey,Macacamulatta,DevelopmentalandComparativeImmunology,2013,40(1):69–77.

(6)LiR,YangH,JiaD,etal.Fusiontoanalbumin-bindingdomainwithahighaffinityforalbuminextendsthecirculatoryhalf-lifeandenhancestheinvivo,antitumoreffectsofhumanTRAIL[J].JournalofControlledReleaseOfficialJournaloftheControlledReleaseSociety,2016,228:96-106.